ARS Pharmaceuticals, Inc. (SPRY): Weighted Average Diluted Shares
98.57M
Year ended 2025-12-31
+35.1%
3-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 98.57M | -3.7% | 2026-03-09, From 2025-01-01 |
| 2024-12-31 | 102.39M | +7.5% | 2026-03-09, From 2024-01-01 |
| 2023-12-31 | 95.22M | +138.3% | 2025-03-20, From 2023-01-01 |
| 2022-12-31 | 39.96M | +38.4% | 2024-03-21, From 2022-01-01 |
| 2021-12-31 | 28.87M | n/a | 2023-03-23, From 2021-01-01 |